BioCentury
ARTICLE | Company News

Tularik screening deal with Molecumetics

February 8, 2001 8:00 AM UTC

Molecumetics (Seattle, Wash.) will provide TLRK with 80,000 compounds that TLRK will screen under its small molecule discovery efforts. TLRK has the option during the next 18 months to purchase an add...